62
Participants
Start Date
October 31, 2007
Primary Completion Date
February 28, 2009
Study Completion Date
February 28, 2009
Probuphine (buprenorphine implant)
Implantable formulation of buprenorphine made of buprenorphine HCl/ethylene vinyl acetate, considered a drug. (4 implants, 6-month duration).
University of Pennsylvania, Treatment Research Center, Philadelphia
Duke Addictions Program, Durham
Amit Vijapura, MD, Jacksonville
Scientific Clinical Research, Inc., North Miami
Psych Care Consultants Research, St Louis
Pahl Pharmaceutical Research, LLC, Oklahoma City
Synergy Clinical Research Center, National City
David Geffen School of Medicine at UCLA, Los Angeles
Fidelity Clinical Research, Inc., Lauderhill
Behavioral Biology Research Unit, Johns Hopkins Bayview Campus, Baltimore
Dual Diagnosis Unit, SSTAR: Stanley Street Treatment and Resources, Inc., Fall River
Wayne State Univ. School of Medicine, Dept of Psychiatry & Behavioral Neuroscience, Detroit
New York VA Medical Center, NYU School of Medicine, New York
Puget Sound Health CareSystem, Seattle
Providence Behavioral Health Services, Everett
Lead Sponsor
Titan Pharmaceuticals
INDUSTRY